This study aims to determine the association between 2-minute heart rate recovery (HRR) and cancer risk. Each participant (5379 women; 8485 men) provided HRR obtained from treadmill tests. The outcome was site-specific cancer. Over 9 years of follow-up, 630 cancer events (258 women) were accrued. Slower HRR was associated with increased thyroid cancer risk in women (P for trend = .0121) and colorectal cancer risk in men (P for trend = .0034). The lowest HRR (<13 bpm) had higher hazards of thyroid cancer (hazard ratio [HR] = 2.20; 95% CI = 1.28-3.77) in women and colorectal cancer (HR = 3.08; 95% CI = 1.32-7.15) in men. In women, slower HRR and lower proportions of heart rate recovery (PHRR) were associated with higher hazards of thyroid cancer in women and metabolically related cancers (liver and colorectal) in men. Slower HRR and lower PHRR were independent risk factors for thyroid cancer in women and metabolically related cancers in men.
Introduction
Evidence indicates that maximal heart rate (HR) is a useful indicator of cardiorespiratory fitness, 1, 2 which is an independent predictor of cancer 3 and cardiovascular disease. 4 As such, reduced resting HR is associated not only with increased levels of cardiorespiratory fitness, 5 but also with a decreased risk of mortality, cardiovascular disease, and cancer. 6 So individuals maximal HR and resting HR both correspond to their cardiorespiratory fitness levels. An indicator that takes into consideration maximal and resting HR associated with exercise-related cardiac functions is HR recovery (HRR) because it represents how fast one's HR can recover following an exercise. HRR can serve as a useful marker for favorable parasympathetic response to exercise 7 and has been known to be associated with various detrimental health outcomes. For example, previous research found that delayed HRR was associated with an increased risk of mortality in healthy 8 and diabetic 9 men. Moreover, research has found HRR to be an independent predictor of incident type 2 diabetes in healthy men. 10 However, evidence on HRR in relation to cancer risk is scarce in both men and women.
The present study investigated the relationships between HRR or proportion of heart rate recovery (PHRR) and the incidence of overall and site-specific cancer in a large populationbased cohort of men and women.
Methods

Study Participants
The Korean Cancer Prevention Study II (KCPS-II) included 270 514 Koreans (153 372 men and 117 142 women) who underwent a health examination at 1 of 18 assessment centers in South Korea; the design and methodology of KCPS-II are described in detail elsewhere. 11, 12 Of the participants, 17 806 finished an exercise treadmill test at the Severance Health Promotion Center, a KCPS-II participating center between 1994 and 2008. Among them, 14 805 who met the inclusion criteria of age >30 years and had available data on blood analysis, smoking status, alcohol intake, and regular exercise were selected for the present study. Participants who had a history of cancer (n = 155), CVD or lung disease (n = 288), VO 2 max <3.5 mL/kg/min, or HRR outliers (<0 or >1000 bpm) in exercise treadmill tests (n = 498) were excluded. The final sample included 13 864 participants (5379 women and 8485 men). The Severance Medical Ethics Committee of Korea approved this study (No. 4-2011-0277 ). All participants gave written informed consent.
Data Collection
Demographic information, smoking status, alcohol consumption, exercise, and medical history of CVD and lung disease were assessed by questionnaires. Participant measurements included weight, height, and blood pressure (BP); participants were seated for the latter. Blood samples were obtained after 12 hours of fasting. Total cholesterol, fasting glucose, and liver enzymes (γ-glutamyl transferase, alanine aminotransferase, aspartate aminotransferase) were measured using an autoanalyzer. Diabetes was defined as fasting glucose ≥126 mg/dL, use of glucose-lowering medication, or history of diabetes. Hypertension was defined as systolic BP ≥140 mm Hg, diastolic BP ≥90 mm Hg, use of hypertension medication, or history of hypertension.
The first exercise question was, "Do you exercise regularly?" Possible responses were "yes" and "no." If participants answered "yes," we multiplied the metabolic equivalent of task (MET) value of each activity (of the 9 options, jogging, rope jumping, walking, mountain climbing, calisthenics, swimming, yoga, aerobics, or golf) by the average length of time spent exercising (hours per exercise) and by the frequency of exercise per week. Finally, MET-hour per week was calculated to estimate the overall volume of physical activity. 13 
Exercise Treadmill Test
HRR was measured after a submaximal graded exercise test with the Bruce protocol on a Q-Stress treadmill (Q-Stress, Quinton). The Bruce protocol is commonly used for both healthy and unhealthy people in most cardiovascular rehabilitation centers. 14, 15 The Bruce treadmill protocol comprises 6 levels, and each level is maintained for 3 minutes: 1.7 miles per hour (mph), with 10% grade at level 1, 2.5 mph with 12% grade at level 2, 3.4 mph with 14% grade at level 3, 4.2 mph with 16% grade at level 4, 5.0 mph with 18% grade at level 5, and 5.5 mph with 20% grade at level 6. Each participant self-administered the submaximal graded exercise test until they reached 85% of their personal target HR determined by applying a predefined formula. For the safety of the participants, ACSM's relative and absolute stopping exercise treadmill test criteria were used. 2, 16 Exercise HR and BP were monitored by an electrocardiogram machine and automatic BP machine, respectively. The same measurements were implemented at rest, 30 to 60 s before the end of each level during submaximal graded exercise test, immediately after the test, and every 2 minutes during recovery.
HRR was calculated as maximal HR minus HR measured 2 minutes into recovery. 17 PHRR was calculated (%) as follows:
Maximal HR 2-Minute recovery HR /Resting pulse rate − ( )     x 100.
Resting pulse rate was obtained during seated blood pressure measurements.
Follow-up and Cancer Outcomes
The mean follow-up period through December 31, 2013, was about 9.0 years. The primary outcomes were incidence of overall and site-specific cancer, including thyroid, colorectal, lung, breast, liver, and prostate based on national cancer registry data and hospitalization records from the medical insurance claims data. Metabolically related cancers were defined as endometrial, breast, and colorectal cancer in women and as liver, colorectal, and bladder cancer in men, given their known significant relationships with physical activity. 18 Cancer death outcomes were derived from the Korean National Statistical Office. Based on the ICD code for primary cause of death, cancer death was categorized into cancer codes C00-C97.
Statistical Analyses
The HRR levels were divided into quartiles of beats per minute of ≥27, 18 to 26, 13 to 17, and <13 bpm in women, and ≥31, 20 to 30, 13 to 19, and <13 bpm in men. PHRR levels were divided into quartiles of ≥38.0, 25 to 37.9, 17 to 24.9, and <17.0 in women, and ≥45, 30 to 44.9, 18 to 29.9, and <18.0 in men.
Cox proportional hazard models were used to assess the independent associations of HRR and PHRR with the risk of cancer death and incidence. The following covariates were included as confounders in the models: age, smoking status (current vs nonsmoker), alcohol consumption (yes vs no), regular exercise (yes vs no), MET-hour per week, hypertension, and diabetes. HRR and PHRR as continuous variables were evaluated by graphic impression from spline plots with knots at 12, 24, 36, 48, and 60 bpm. A sensitivity analysis was performed to examine if the HRRcancer associations changed after additional adjustment for cardiorespiratory fitness.
All analyses were performed separately for men and women, using SAS statistical software, version 9.2 (SAS Institute Inc, Cary, NC) and Stata version 11.0 (StataCorp, College Station, TX).
Results
Of the final sample of 13 864 participants, there were 630 cancer cases (258 women and 372 men). Baseline characteristics according to HRR quartiles are provided for women and men separately in Table 1 . In the highest quartile (HRR ≥27 bpm for women and ≥31 bpm for men), the average ages were 44 and 45 years; diabetes prevalence was 1.8% and 4.3%; and hypertension prevalence was 15.8% and 24.9% for women and men, respectively. There were no significant differences between HRR levels and alcohol intake, smoking status, regular exercise, and MET-hour per week values. Type 2 diabetes and hypertension had significant differences between the HRR levels. Table 2 shows hazard ratios (HRs, 95% CIs) of overall and site-specific cancer incidence for the different HRR levels in women. After adjusting for potential confounders (age, smoking status, alcohol intake, regular exercise, MET-hour per week, hypertension, and diabetes) with the Abbreviations: GGT, γ-glutamyltransferase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; MET, metabolic equivalent of task. a Data are expressed as mean (SD) unless otherwise indicated. HRR = Maximal heart rate − 2-Minute recovery heart rate.
highest group of HRR ≥27 bpm as the reference, the relationship between slower HRR and overall cancer incidence was not significant. However, slower HRR had a higher hazard of thyroid cancer incidence (HRR 18-26 bpm: HR = 1.89, 95% CI = 1.09-3.27; HRR 13-17 bpm: HR = 1.54, 95% CI = 0.84-2.81; HRR <13 bpm: HR = 2.20, 95% CI = 1.28-3.77); there was a significant difference between the HRR quartiles, except for HRR 13 to 17 bpm (P for trend = .0121). A significant association of HRR with metabolically related cancer was found only in the HRR 13 to 17 bpm group (HR = 2.37, 95% CI = 1.18-4.73; P for trend = .1190). Table 3 presents HRs and CIs of overall cancer and site-specific cancer incidence according to PHRR level in women. After adjusting for potential confounders (age, smoking status, alcohol intake, regular exercise, MET-hour per week, hypertension, and diabetes) with the highest group PHRR ≥38 as the reference, the association of slower PHRR with overall cancer risk was not significant. However, slower PHRR had a higher hazard of thyroid cancer incidence (PHRR 25.0-37.9: HR = 1.58, 95% CI = 0.91-2.73; PHRR 17.0-24.9: HR = 1.61, 95% CI = 0.92-2.84; PHRR <17.0: HR = 1.93, 95% CI = 1.13-3.31; P for trend = .0221). Compared with the HRR quintiles, the PHRR quintiles showed a lower correlation with the incident rate of thyroid cancer. Table 4 shows HRs and CIs of overall cancer and site-specific cancer incidence according to the HRR level in men. After adjusting for confounders with the highest HRR group of ≥31 bpm as the reference, the relationship of slower HRR with overall cancer risk was not significant. However, hazards of colorectal cancer incidence were higher for slower HRR (HRR 20-30 bpm: HR = 1.37, 95% CI = 0.54-3.48; HRR 13-19 bpm: HR = 2.27, 95% CI = 0.93-5.55; HRR <13 bpm: HR = 3.08, 95% CI = 1.32-7.15). Only the lowest HRR (<13 bpm) group showed a statistically significant association, but slower HRR was associated with colorectal cancer risk (P for trend = .0034). Slower HRR also exhibited a higher hazard of metabolically related cancer (liver, colorectal, and bladder) incidence (HRR 20-30 bpm: HR = 1.16, 95% CI = 0.57-2.40; HRR 13-19 bpm: HR = 2.62, 95% CI = 1.33-5.16; HRR <13 bpm: HR = 3.83, 95% CI = 2.01-7.32; P for trend <.0001). Additional adjustment for cardiorespiratory fitness made no meaningful changes to the associations in women and men (data not shown). Table 5 presents HRs and CIs of overall cancer and site-specific cancer incidence according to PHRR level in men. After adjusting for confounders with the highest PHRR group of ≥45 as the reference, there was no statistical significance for the association between slower PHRR and overall cancer risk. However, slower PHRR had a higher hazard of colorectal cancer incidence (PHRR 30.0-44.9: HR = 1.22, 95% CI = 0.44-3.37; PHRR 18.0-29.9: HR = 2.03, 95% CI = 0.81-5.11; PHRR <18.0: HR = 3.35, 95% CI = 1.42-7.90) and metabolically related cancer-liver, colorectal, and bladder (PHRR 30.0-44.9: HR = 0.91, 95% CI = 0.43-1.93; PHRR 18.0-29.9: HR = 1.49, 95% CI = 0.74-2.98; PHRR <18.0: HR = 3.11, 95% CI = 1.65-5.85). Statistical significance was observed only in the association of the lowest PHRR (<18) group with colorectal cancer risk (P for trend = .0014) and metabolically related cancer risk (P for trend = .0001). Spline plots of the incidence of thyroid cancer and colorectal cancer with HRR as continuous variables are presented in Figures 1 and 2 , respectively. Slower HRR showed a linear association with thyroid cancer incidence in women. However, in men, slower HRR showed a tendency for linear associations with a higher incident rate of colorectal cancer at HRR <40 bpm.
Discussion
In our study, slower HRR was associated with an increased risk of thyroid cancer in women. In men, slower HRR and lower PHRR were associated with an increased risk of metabolically related cancer, including liver and colorectal cancers. However, the associations of HRR and PHRR with overall cancer were not significant in both women and men. Metabolic syndrome has been used to predict various cancer risks and involves a constellation of metabolic disorders, including low physical activity levels, high caloric intake, low fiber intake, and high oxidative stress. 19 According to a meta-analysis, metabolic syndrome related with physical inactivity was highly associated with liver and colorectal cancer in men and was significantly related with (in order of decreasing prevalence) endometrial, breast, colorectal, and pancreatic cancer in women. 18 Available methods to estimate physical activity included mechanical devices, electronic monitors (heart rate, pedometers), and behavioral observation. 20 As an indicator of favorable parasympathetic response to exercise, 7 HRR as measured from an exercise treadmill test was used in the present study. In men, lower HRR had consistently higher hazards of metabolically associated cancers, including liver and colorectal cancer, but in women, only the mid-HRR of 13 to 17 bpm had a significant association with metabolically related cancers, including cervix, breast, and colorectal cancer. This indicates a gender difference in terms of the incident rate of metabolically associated cancers, suggesting that men may reduce the risk of metabolic cancers at a greater rate than women by increasing HRR (which can be achieved through improvements in cardiorespiratory fitness). Regular participation in physical activity can not only improve cardiorespiratory fitness, but also lower levels of insulin, some hormones, and growth factors, which can then lead to reduced risk of developing breast, colorectal, and endometrial cancer. 21 To be specific, increasing physical activity can make favorable changes on the levels of chemical messengers, called prostaglandins, which have been associated with tumor growth. Prostaglandin F2 α inhibits tumor growth in the colon and increases gut motility; prostaglandin E2 decreases colonic motility and increases the rate of colon cancer cells. 22 
Figure 1.
Hazard ratios (HRs) of thyroid cancer incidence according to heart rate recovery (HRR) in women. HRR = Maximal heart rate − 2-Minute recovery heart rate.
Figure 2.
Hazard ratios (HRs) of colorectal cancer incidence according to heart rate recovery (HRR) in men. HRR = Maximal heart rate − 2-Minute recovery heart rate.
In the present study, there was a significant association between HRR and thyroid cancer in women, which is consistent with a previous population-based study of Korean women that found inverse associations between exercise and thyroid cancer risk. 23 However, a previous systematic review 24 and meta-analysis of cohort studies 25 concluded that there was no significant association between physical activity and thyroid cancer. 24 Nevertheless, compelling evidence suggests that physical activity increases the amount of circulating sex-hormone binding globulin, which binds to these sex hormones and reduces their ability to influence target tissues and reduce the proliferation of thyroid cancer cells. 26, 27 There were several limitations in our study. First, the study participants had their health checkup voluntarily and, thus, may not represent a general adult population in South Korea. Second, we could not find a strong correlation between HRR and incident rates of various cancers (including lung and breast cancer) because of the relatively short follow-up period and very low incident rate of cancers. Third, this study analyzed metabolically related cancers as outcome variables, but the statistical models were not adjusted for dietary intake, which is a predictor of metabolic disorders. Another limitation is the lack of information on menstruation status, which may be an important confounder for the HRR-cancer associations in women. Moreover, the present analysis did not adjust for medication use (eg, β-blockers), which may influence heart rate responses. In addition, PHRR was calculated using resting pulse rate because of the lack of resting heart rate measured before the exercise test. However, this study is still valuable in that it is the first study to investigate the relationships between objectively measured HRR and the incidence of various cancers.
In conclusion, slower HRR and lower PHRR levels are independent risk factors for thyroid cancer in women and colorectal cancer in men. Men with slower HRR and lower PHRR levels had a significant association with metabolically related cancer risk, including liver and colorectal cancers. This study provides further evidence that promoting physical activity can be an effective behavioral strategy for the prevention of cancer in adults. More research is needed to investigate the associations of HRR as well as exercise parameters with site-specific cancer risks.
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